T. Rowe Price Investment Management, Inc. Exact Sciences Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 4,269,823 shares of EXAS stock, worth $228 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
4,269,823
Previous 3,392,838
25.85%
Holding current value
$228 Million
Previous $231 Million
3.81%
% of portfolio
0.15%
Previous 0.14%
Shares
10 transactions
Others Institutions Holding EXAS
# of Institutions
664Shares Held
152MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$935 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$908 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$643 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$332 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$307 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.44B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...